Want to see NVNO full AI Analyst Report?
enVVeno Medical (NVNO) Ratios
376 Followers
enVVeno Medical Ratios
NVNO's free cash flow for Q3 2026 was $-3.18M. For the 2026 fiscal year, NVNO's free cash flow was increased by $0.00 and operating cash flow was $-3.18M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 13.58 | 20.88 | 34.23 | 25.78 | 34.83 |
| Quick Ratio | 13.58 | 20.88 | 34.23 | 25.78 | 34.83 |
| Cash Ratio | 1.44 | 0.84 | 2.64 | 2.98 | 34.64 |
| Solvency Ratio | -7.81 | -7.62 | -9.43 | -8.23 | -4.88 |
| Operating Cash Flow Ratio | -7.34 | -8.04 | -13.75 | -10.21 | -7.50 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -46.26 | -55.79 | -49.74 | -40.69 |
| Net Current Asset Value | $ 26.39M | $ 40.94M | $ 44.49M | $ 36.50M | $ 51.75M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.02 | 0.03 | 0.04 | 0.03 |
| Debt-to-Equity Ratio | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 |
| Debt-to-Capital Ratio | 0.03 | 0.02 | 0.03 | 0.04 | 0.04 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.09 | 1.07 | 1.05 | 1.08 | 1.06 |
| Debt Service Coverage Ratio | 0.00 | -58.49 | -67.96 | -76.89 | -55.22 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.24 | 0.18 | 0.19 | 0.18 |
| Interest Debt Per Share | 1.19 | 76.04 | 139.61 | 187.19 | 283.09 |
| Net Debt to EBITDA | 0.12 | 0.03 | 0.10 | 0.12 | 3.28 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 93.17% | 91.58% | 93.18% | 98.95% | 97.84% |
| Return on Assets (ROA) | -65.87% | -48.54% | -48.35% | -59.21% | -28.64% |
| Return on Equity (ROE) | -71.77% | -51.75% | -50.90% | -63.70% | -30.38% |
| Return on Capital Employed (ROCE) | -76.16% | -55.59% | -53.40% | -62.13% | -30.10% |
| Return on Invested Capital (ROIC) | -75.10% | -55.12% | -52.64% | -61.17% | -29.79% |
| Return on Tangible Assets | -65.87% | -48.54% | -48.35% | -59.21% | -28.64% |
| Earnings Yield | -289.99% | -1453.33% | -1282.46% | -1485.30% | -996.31% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.52 | 1.28 | 0.81 | 0.81 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | -695.44 | -285.45 | -450.51 | -451.37 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 695.44 | 285.45 | 450.51 | 451.37 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -26.43 | -1203.32 | -1877.91 | -1703.83 | -1671.73 |
| Free Cash Flow Per Share | -26.44 | -1205.96 | -1881.20 | -1716.37 | -1723.64 |
| Dividend Paid and CapEx Coverage Ratio | -3113.60 | -455.08 | -571.45 | -135.82 | -32.20 |
| Capital Expenditure Coverage Ratio | -3113.60 | -455.08 | -571.45 | -135.82 | -32.20 |
| Operating Cash Flow Coverage Ratio | -22.24 | -15.83 | -13.45 | -9.10 | -5.91 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -231.93% | -1124.02% | -1030.23% | -947.33% | -736.25% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.34 | -0.07 | -0.08 | -0.07 | -0.10 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 0.25 | 0.04 | 0.04 | 0.04 | 0.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.43 | -0.09 | -0.10 | -0.11 | -0.14 |
| Price-to-Operating Cash Flow Ratio | -0.43 | -0.09 | -0.10 | -0.11 | -0.14 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.01 | -0.00 | 0.00 |
| Enterprise Value Multiple | -0.23 | -0.04 | 0.02 | 0.05 | 3.18 |
| Enterprise Value | 4.35M | 811.31K | -384.33K | -1.18M | -51.06M |
| EV to EBITDA | -0.23 | -0.04 | 0.02 | 0.05 | 3.18 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -0.28 | -0.05 | 0.02 | 0.07 | 4.18 |
| EV to Operating Cash Flow | -0.28 | -0.05 | 0.02 | 0.08 | 4.31 |
| Tangible Book Value Per Share | 46.06 | 3012.86 | 4600.68 | 4224.83 | 7677.70 |
| Shareholders’ Equity Per Share | 46.06 | 3012.86 | 4600.68 | 4224.83 | 7677.70 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -33.06 | -1559.28 | -2341.76 | -2691.07 | -2332.46 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.80 | 0.77 | 0.80 | 0.63 | 0.72 |
Currency in USD
